Trial Profile
Food effect and dosage form comparison study of TAS-118
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2017
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur/folinic acid (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Taiho Pharmaceutical
- 07 Feb 2017 Status changed from active, no longer recruiting to completed.
- 08 Jun 2016 New trial record